Zymeworks R&D Spending Growth & History (ZYME)
Zymeworks's r&d spending was $137.0M for fiscal 2025.
View full Zymeworks company overviewZymeworks annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $137.0M | $2.4M | +1.77% |
| 2024 | 2024-12-31 | $134.6M | −$9.0M | −6.27% |
| 2023 | 2023-12-31 | $143.6M | −$65.0M | −31.15% |
| 2022 | 2022-12-31 | $208.6M | $8.8M | +4.43% |
| 2021 | 2021-12-31 | $199.8M | $28.5M | +16.68% |
| 2020 | 2020-12-31 | $171.2M | — | — |
Zymeworks quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $27.4M | −$7.0M | −20.36% |
| Q1 2026 | 2026-03-31 | $34.5M | −$1.3M | −3.58% |
| Q4 2025 | 2025-12-31 | $31.2M | −$5.8M | −15.72% |
| Q3 2025 | 2025-09-30 | $35.6M | −$775,000 | −2.13% |
| Q2 2025 | 2025-06-30 | $34.4M | $5.3M | +18.13% |
| Q1 2025 | 2025-03-31 | $35.7M | $3.7M | +11.53% |
| Q4 2024 | 2024-12-31 | $37.1M | $11.5M | +45.21% |
| Q3 2024 | 2024-09-30 | $36.4M | $3.6M | +10.92% |
| Q2 2024 | 2024-06-30 | $29.2M | −$10.2M | −26.00% |
| Q1 2024 | 2024-03-31 | $32.0M | −$13.9M | −30.21% |
| Q4 2023 | 2023-12-31 | $25.5M | −$27.4M | −51.81% |
| Q3 2023 | 2023-09-30 | $32.8M | −$4.3M | −11.65% |
| Q2 2023 | 2023-06-30 | $39.4M | −$16.6M | −29.66% |
| Q1 2023 | 2023-03-31 | $45.9M | −$16.6M | −26.55% |
| Q4 2022 | 2022-12-31 | $53.0M | — | — |
| Q3 2022 | 2022-09-30 | $37.1M | −$12.8M | −25.65% |
| Q2 2022 | 2022-06-30 | $56.0M | — | — |
| Q1 2022 | 2022-03-31 | $62.5M | — | — |
| Q3 2021 | 2021-09-30 | $49.9M | — | — |
Zymeworks r&d spending trends
Over the last five fiscal years, Zymeworks's r&d spending decreased from $171.2M to $137.0M, a change of −$34.2M. The latest reported quarter, Q2 2026, shows $27.4M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zymeworks source filings ↗